Printer Friendly
The Free Library
14,800,756 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Getting a grip on HIV's crucial enzyme.


The AIDS-causing virus HIV HIV (Human Immunodeficiency Virus), either of two closely related retroviruses that invade T-helper lymphocytes and are responsible for AIDS. There are two types of HIV: HIV-1 and HIV-2. HIV-1 is responsible for the vast majority of AIDS in the United States.  must copy its genetice material -- composed of RNA RNA: see nucleic acid.
RNA
 in full ribonucleic acid

One of the two main types of nucleic acid (the other being DNA), which functions in cellular protein synthesis in all living cells and replaces DNA as the carrier of genetic
 -- into DNA DNA: see nucleic acid.
DNA
 or deoxyribonucleic acid

One of two types of nucleic acid (the other is RNA); a complex organic compound found in all living cells and many viruses. It is the chemical substance of genes.
 soon after it infects a cell. To do this, it employes reverse transcriptase, an enzyme that uses RNA as a template for making DNA and then destroys the RNA template. AIDS drugs such as zidovudine (AZT) and didanosine didanosine /di·dan·o·sine/ (-dan´o-sen) 2, an analogue of dideoxyadenosine; an antiretroviral agent used for the treatment of advanced HIV-1 infection and acquired immunodeficiency syndrome, administered orally.  (DDI ddI and ddC: see AZT. ) work by blocking the action of this enzyme, but HIV can sometimes become resistant to these compounds.

This computer model of the enzyme at work, created using X-ray crystallography data, may help scientists design drugs HIV can't elude. It shows how part of the ribbon-like reverse transcriptase enzyme (top right) interacts with a double helix (bottom) made of one strand of RNA and one strand of DNA. The spheres at right highlight the enzyme's site for digesting the RNA template. The spheres at left depict where another part of the enzyme (not shown) adds to the growing DNA chain. The model was created by two teams of researchers led by Edward Arnold at Rutgers University in Piscataway, N.J., and Stephen H. Hughes at the National Cancer Institute facility in Frederick, Md. They report their finding in the May 7 NATURE.
COPYRIGHT 1992 Science Service, Inc.
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1992, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Title Annotation:reverse transcriptase
Author:Ezzell, Carol
Publication:Science News
Article Type:Brief Article
Date:May 9, 1992
Words:194
Previous Article:New crystal makes paper bright. (calcium carbonate) (Brief Article)
Next Article:Tamoxifen trial begins amid new concerns. (Brief Article)
Topics:



Related Articles
First 3-D image of AIDS virus protein. (aspartyl protease)
Novel buckyball blocks AIDS virus enzyme. (carbon molecules)
Cosalane halts HIV infection. (new compound inhibits HIV from infecting human immune cells in the laboratory) (Brief Article)
Take-home message: no AIDS magic bullet. (bombarding HIV virus with multiple drugs does not disable reverse transcriptase) (Brief Article)
AIDS update '96: new drugs, new tests, new optimism mark recent AIDS research.
New Compounds Inhibit HIV in Lab.
Lactic acidosis during nucleoside antiretroviral HIV therapy.(Letters to the Editor)(Letter to the Editor)
False-positive human immunodeficiency virus test and Trypanosoma cruzi infection in eastern Colombia.(Letters to the Editor)(Letter to the Editor)
New protease inhibitor looks promising.(Biomedicine)(TMC114)(Tibotec of Mechelen)(Brief Article)
Integrase inhibitors: first clear success in human trial.

Terms of use | Copyright © 2010 Farlex, Inc. | Feedback | For webmasters | Submit articles